Ranking of the 2nd-look transurethral electroresection of the superficial carcinoma of the bladder

被引:6
作者
Engelhardt, PF [1 ]
Simak, R [1 ]
Daha, LK [1 ]
Plas, E [1 ]
Pflüger, H [1 ]
机构
[1] KH Lainz, Urol Abt, A-1130 Vienna, Austria
关键词
superficial bladder cancer; transurethral resection; residual cancer;
D O I
10.1055/s-2001-15848
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: Repeat transurethral resection (TUR) for superficial bladder cancer is supposed to a chieve better tumor control and to reduce the number of residual tumors, hence to lower the rate of short-time recurrences. We evaluated the role of a routine second transurethral resection in superficial bladder cancer. Methods: From January 1996 to December 1998, 75 patients with newly diagnosed superficial bladder cancer underwent repeat transurethral resection 8 weeks after the first TUR. We compared the tumor stages, grades, changes in histopathology and the presence of residual tumors after the initial TUR. Results: Residual tumors was verified in 24 patients (32%) on repeat TUR. Stratified by tumors stage at first TUR, residual tumor were seen in 10% of pTaG1, 20,5% of pTaG2, 50% of pTaG3, 50% of pT1G2 and 52,6% of pT1G3 of patients respectively. Residual cancer was endoscopically detectable in 22 of 24 patients. Repeat TUR of unsuspicious former resection sites never revealed residual lesions after initial pTaG1-G2 cancer, and overall residual cancer in only 2 of 75 patients. Conclusions: A significant number of patients with superficial bladder cancer has residual lesions after initial TUR. Routine repeat TUR in all patients can however be limited to high risk cancer (pTaG3, pT1G1-3), since the vast majority of residual lesions remains cystoscopically detectable.
引用
收藏
页码:173 / 177
页数:5
相关论文
共 20 条
[1]   FOLLOW-UP OF PATIENTS WITH SUPERFICIAL TRANSITIONAL-CELL CARCINOMA OF THE BLADDER - THE CASE FOR A CHANGE IN POLICY [J].
ABEL, PD .
BRITISH JOURNAL OF UROLOGY, 1993, 72 (02) :135-142
[2]   THE DANGERS OF A LONG UROLOGICAL WAITING LIST [J].
BISHOP, MC .
BRITISH JOURNAL OF UROLOGY, 1990, 65 (05) :433-440
[3]  
Brausi M, 1998, J UROLOGY, V159, P143
[4]  
CUTLER SJ, 1982, AUA MONOGRAPHS BLADD, V1, P35
[5]  
FLAMM J, 1991, UROLOGE A, V30, P111
[6]  
FLAMM J, 1988, ACTA CHIR AUST S, V77, P1
[7]   SURVIVAL WITH BLADDER-CANCER, EVALUATION OF DELAY IN TREATMENT, TYPE OF SURGEON, AND MODALITY OF TREATMENT [J].
GULLIFORD, MC ;
PETRUCKEVITCH, A ;
BURNEY, PGJ .
BRITISH MEDICAL JOURNAL, 1991, 303 (6800) :437-440
[8]   SUPERFICIAL BLADDER-CANCER - PROGRESSION AND RECURRENCE [J].
HENEY, NM ;
AHMED, S ;
FLANAGAN, MJ ;
FRABLE, W ;
CORDER, MP ;
HAFERMANN, MD ;
HAWKINS, IR .
JOURNAL OF UROLOGY, 1983, 130 (06) :1083-1086
[9]   The value of a second transurethral resection in evaluating patients with bladder tumors [J].
Herr, HW .
JOURNAL OF UROLOGY, 1999, 162 (01) :74-76
[10]   THE RELATIONSHIP AMONG MULTIPLE RECURRENCES, PROGRESSION AND PROGNOSIS OF PATIENTS WITH STAGES TA AND T1 TRANSITIONAL-CELL CANCER OF THE BLADDER FOLLOWED FOR AT LEAST 20 YEARS [J].
HOLMANG, S ;
HEDELIN, H ;
ANDERSTROM, C ;
JOHANSSON, SL .
JOURNAL OF UROLOGY, 1995, 153 (06) :1823-1826